Pricing Log in Create free account
Saturday 17 October 2026 Export HCTI’s income statement to Excel — free account

Healthcare Triangle, Inc.

HCTI Healthcare Health Information Services

Healthcare Triangle, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.9 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue grew 158.4%, EPS grew 95.5%, free cash flow grew 67.5% and total debt rose 2,749.9%, each against the same quarter a year earlier.

0.40 0.02 −4.76%
Market cap
$7.4M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
n/a
Altman Z
−3.33
Beneish M
0.56
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 7.40
Revenue 25.68
Net Income (17.02)
Free Cash Flow (17.58)
Net Debt 9.92
Current Ratio 0.60 (below 1: weak)
Debt/Equity 0.24 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E (0.14) (negative: loss-making)
P/S ratio 0.04
P/B ratio 0.05
Past 5Y EPS Growth —
This Y EPS Growth 77.05% (at or above 15%: strong)
Next Y EPS Growth 68.91% (at or above 15%: strong)
Next Y revenue growth 179.61% (at or above 10%: strong)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.4×, against a ten-year median of 0.4×; over the ten years it ranged from −0.4× in 2025 to 354,317× in 2021.
P/S against its own 10 years 5.41%
10-year low 10-year high
P/B against its own 10 years 0.21%
10-year low 10-year high
EV/Sales against its own 10 years 47.41%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 1 0 8 2
Receivables 4 1 2 6
Inventory — — — —
Other 1 0 3 2
6 1 13 10
2023 2024 2025 Q'26
Payables 2 3 1 1
ST’ Debt 4 3 11 9
Other 2 2 1 5
8 7 13 16

Compound Annual Growth %

10y 5y 3y
Sales — (15.02%) (32.85%)
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 18.10% (7.06%)

Revenue $m

Mar Jun Sep Dec Year
’26 10 9 — — —
’25 4 4 3 3 14
’24 4 3 2 2 12
’23 10 9 8 7 33
’22 11 12 12 11 46
’21 8 10 8 9 35
’20 — 8 7 — 31
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (7) (1) — — —
’25 (6) (3) (1) (7) (17)
’24 0 (1) 1 (1) (1)
’23 (2) (1) 0 1 (2)
’22 0 0 (1) (2) (3)
’21 (2) (1) 0 (3) (7)
’20 — — (2) 1 (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (7) (1) — — —
’25 (6) (3) (3) (7) (18)
’24 0 (1) 1 (1) (1)
’23 (2) (1) 0 1 (2)
’22 0 (2) (2) (2) (6)
’21 (2) (1) 0 (6) (10)
’20 — — (2) 1 (1)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (6.81) (1.56) — — —
’25 (2.54k) (34.73) (25.15) 2.49k (152.30)
’24 (6.29k) (4.19k) (3.29k) (3.44k) (16.92k)
’23 (11.98k) (6.29k) (6.89k) (6.30k) (31.12k)
’22 (0.06) (1.71k) (10.48k) (19.46k) (38.92k)
’21 (0.03) 0.01 (0.07) (0.12) (0.20)
’20 — 0.00 0.01 — 0.08
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — 233,064.00 16,583.40 25,696.80 4,332.60 36.00

Analyst estimates 2026–2028

Powerpack
High — — — — — 649,890.00 286,848.00 162,696.59 63,345.60 26,145.00
People
People Employees — — — — 69 77 51 33 36 84
Revenue/emp, $m — — — 0.00 0.45 0.46 0.90 1.01 0.32 0.17
Income, $m
Income, $m Revenue — — — 29 31 35 46 33 12 14
Gross margin, % — — — 20.35 27.40 29.83 24.62 20.41 24.71 13.61
EBT — — — 2 3 (6) (10) (9) (6) (9)
EBT margin, % — — — 5.63 8.33 (16.80) (20.81) (26.05) (50.93) (68.22)
Net income — 0 — 1 2 (6) (10) (9) (6) (9)
Depreciation — — — 1 1 1 3 2 2 1
Per share, $
Per share, $ Revenue — — — 8.17 1.12 1.20 229,430.00 110,676.67 29,240.00 224.41
Earnings — — — 0.33 0.08 (0.20) (38,922.15) (31,115.08) (16,916.17) (152.30)
Cash flow — — — 1.13 (0.03) (0.24) (13,000.00) (7,170.00) (2,702.50) (266.93)
Capex — — — (1.04) (0.02) (0.11) (16,595.00) (40.00) 0.00 (24.30)
Free cash flow — — — 0.09 (0.04) (0.35) (29,595.00) (7,210.00) (2,702.50) (291.23)
Book value — — — 0.56 0.16 0.55 61,940.00 (4,636.67) (12,785.00) 160.65
Shares, m — — — 4 28 29 0 0 0 0
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S — — — 462,544.22 462,544.22 225,623.57 0.12 0.39 0.50 0.17
P/B — — — 5,712,467.18 5,712,467.18 493,197.59 0.46 0.00 0.00 0.94
EV/Sales — — — 462,544.24 462,544.24 225,623.58 0.15 0.47 0.80 0.46
EV/FCF — — — (5,812,716.34) (5,812,716.34) (1,103,770.48) (0.75) (2.84) (3.97) (0.35)
Cash, $m
Cash, $m Operating cash flow — — — 4 (1) (7) (3) (2) (1) (17)
Capex — — — (4) 0 (3) (3) 0 — (2)
Free cash flow — — — 0 (1) (10) (6) (2) (1) (18)
Balance, $m
Balance, $m Working capital — — — (1) 1 6 2 (2) (6) 0
Total debt — — — — 1 2 2 4 3 11
Net debt — — — (1) (1) 0 1 3 3 3
Shareholders’ equity — — — 2 4 16 12 (1) (5) 10
Returns, %
Returns, % ROA — — — 28.41 24.31 (33.31) (42.36) (62.89) (135.37) (76.74)
ROIC — — — 104.31 19.98 (20.20) (48.37) (381.70) 0.00 (46.86)
ROE — — — 37.19 74.67 (58.14) (67.38) (157.97) 85.64 188.76
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Healthcare Triangle, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
RNLXY Renalytix plc - Sponsored ADR $17.2M — (loss-making) — +13.73% (above 0%: growing) n/m +17.96% (above 0%: growing) 19.16% (783.91%) Compare
BFRG Bullfrog AI Holdings Inc. $9.9M — (loss-making) — +2,054.00% (above 0%: growing) n/m −5.67% (below 0%: shrinking) 49.63% (658.82%) Compare
ETAOF ETAO International Co., Ltd. $9.8M — (loss-making) — — n/m +37,595.70% (above 0%: growing) — 0.00% Compare
HCTI Healthcare Triangle, Inc. $7.4M 0.0× — (loss-making) +158.38% (above 0%: growing) n/m +67.48% (above 0%: growing) 22.48% (44.28%)
MGRX Mangoceuticals, Inc. $7.1M — (loss-making) — −59.07% (below 0%: shrinking) n/m +79.27% (above 0%: growing) 64.24% (1,501.45%) Compare
HLTHQ Cue Health Inc. $6.9M — (loss-making) — (loss-making) −87.19% (below 0%: shrinking) n/m +50.55% (above 0%: growing) (90.14%) (792.13%) Compare
ZCMD Zhongchao Inc. $6.2M — (loss-making) — +20.44% (above 0%: growing) −550.00% (below 0%: shrinking) +191.85% (above 0%: growing) 41.67% 0.00% Compare
ACON Aclarion, Inc. $5.6M — (loss-making) — (loss-making) +30.57% (above 0%: growing) n/m −41.41% (below 0%: shrinking) 32.94% (11,506.75%) Compare
VSEED VSee Health, Inc. $2.8M — (loss-making) — (loss-making) +48.02% (above 0%: growing) n/m −257.62% (below 0%: shrinking) 13.20% (172.69%) Compare
Median of peers $7.0M — — +20.44% — +34.25% 32.94% (721.36%)

All 51 Health Information Services stocks →

Healthcare Triangle, Inc. (HCTI) key facts

  • Strength: Healthcare Triangle, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.9 million, up 18.8% from fiscal 2024.
  • Healthcare Triangle, Inc. (HCTI) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, HCTI traded at $0.40, a market capitalization of $7.4 million.
  • Return on equity was 188.8% and debt-to-equity 0.24.
  • Its Altman Z-score is −3.33 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Healthcare Triangle, Inc. (HCTI) Latest News

14 May

Impact 5 ·
Impact 5 ·
stockrow.com/HCTI · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com